Hennion & Walsh Asset Management’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-42,694
| Closed | -$6.45M | – | 826 |
|
|
2022
Q3 | $6.45M | Sell |
42,694
-1,781
| -4% | -$269K | 0.42% | 51 |
|
|
2022
Q2 | $6.48M | Sell |
44,475
-40,134
| -47% | -$5.85M | 0.4% | 56 |
|
|
2022
Q1 | $10M | Sell |
84,609
-2,738
| -3% | -$325K | 0.53% | 37 |
|
|
2021
Q4 | $12M | Sell |
87,347
-26,939
| -24% | -$3.71M | 0.59% | 32 |
|
|
2021
Q3 | $15.9M | Buy |
114,286
+924
| +0.8% | +$128K | 0.83% | 17 |
|
|
2021
Q2 | $11M | Buy |
113,362
+15,864
| +16% | +$1.54M | 0.59% | 29 |
|
|
2021
Q1 | $6.66M | Buy |
+97,498
| New | +$6.66M | 0.4% | 54 |
|